Form D · Biotechnology
Humacyte, Inc.
Durham, NC · CIK 0001385943
Offering snapshot reported Jun 26, 2018 · SEC filing
- Reported sold
- $150M Offering amount: $150M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 25, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 26, 2018 | Initial | $150,000,000 | No comparison | 1 | SEC filing |
| Mar 9, 2018 | Initial | $74,999,980 | No comparison | 29 | SEC filing |
| Jan 20, 2015 | Amendment | $49,762,373 | $12,500,000vs Jan 21, 2014 | 6 | SEC filing |
| Jan 21, 2014 | Amendment | $37,262,373 | $15,262,373vs Apr 9, 2012 | 6 | SEC filing |
| Apr 9, 2012 | Amendment | $22,000,000 | $10,000,000vs Sep 2, 2010 | 2 | SEC filing |
| Sep 2, 2010 | Amendment | $12,000,000 | $5,000,000vs Nov 23, 2009 | 1 | SEC filing |
| Nov 23, 2009 | Amendment | $7,000,000 | No comparison | 1 | SEC filing |
| Oct 16, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-315399
Source: Form D, filed Jun 26, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Anderson | Director |
| Paul A. Boyer | Executive |
| Carrie S. Cox | Director, Executive |
| Brady W. Dougan | Director |
| Robert S. Langer | Director |
| Jeffrey H. Lawson | Executive |
| Theodore D. Lithgow | Executive |
| Ted Lithgow | Executive |
| Matthew Megaro | Director |
| Laura E. Niklason | Director |
| Dale A. Sander | Director |
| Kathleen Sebelius | Director |
| William Tente | Executive |
| Max N. Wallace | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2525 E. Nc Highway 54
Durham, NC, 27713
Durham, NC, 27713